Sage Journals: Discover world-class research

Free access

Research article

First published 2015-3

Development of sotagliflozin,a dual sodium-dependent glucose transporter 1/2 inhibitor

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph [...]

Diabetes & Vascular Disease Research

Free access

Review article

First published 2014-10

Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes

Bernard Peene, Katrien Benhalima

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2024

Neomangiferin,a Naturally Occurring Mangiferin Congener,Inhibits Sodium-Glucose Co-transporter-2: An In silico Approach

Ayobami J Olusola, Samson O Famuyiwa, Kolade O Faloye [...]

Bioinformatics and Biology Insights

Open access

Research article

First published 2022-3

Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis

Cheng-Wei Lin, Shih-Yuan Hung, I-Wen Chen

Journal of International Medical Research

Free access

Brief report

First published 2018-3

Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure

Tsuneo Takenaka, Yoichi Ohno, Hiromichi Suzuki

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2025-12

Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout Risk: A Two-Step Mendelian Randomization Study

Huiqiong Zeng, Zebo Cai, Junda Lai [...]

ASSAY and Drug Development Technologies

Retricted access

Research article

First published 2025-3

Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Genitourinary Infections at HbA1c ≥10%: A Population Health-Based Retrospective Review

Bryce Ashby, Marina Kawaguchi-Suzuki, Yvette Grando Holman [...]

Annals of Pharmacotherapy

Open access

Case report

First published 2016-9

Sodium glucose co-transporter 2 inhibitors in patients with resistant hypertension: a case study

Amira Obeid, Mark Pucci, Una Martin [...]

JRSM Open

Free access

Brief report

First published 2017-5

Sodium–glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy

Tsuneo Takenaka, Miyako Kishimoto, Mari Ohta [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2022-05-17

Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes

Serena Low, Kiat Sern Goh, Tze Pin Ng [...]

Journal of Alzheimer’s Disease

Search results